<SEC-DOCUMENT>0001104659-24-125505.txt : 20241204
<SEC-HEADER>0001104659-24-125505.hdr.sgml : 20241204
<ACCEPTANCE-DATETIME>20241204160509
ACCESSION NUMBER:		0001104659-24-125505
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20241202
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241204
DATE AS OF CHANGE:		20241204

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Armata Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0000921114
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				911549568
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37544
		FILM NUMBER:		241526196

	BUSINESS ADDRESS:	
		STREET 1:		5005 MCCONNELL AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90066
		BUSINESS PHONE:		310-665-2928

	MAIL ADDRESS:	
		STREET 1:		5005 MCCONNELL AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90066

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AmpliPhi Biosciences Corp
		DATE OF NAME CHANGE:	20130222

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGETED GENETICS CORP /WA/
		DATE OF NAME CHANGE:	19940331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2430081d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:armp="http://armatapharma.com/20241202">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_armp_armatapharma.com_20241202 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20241202_20241202 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0000921114 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000004" name="dei:EntityCentralIndexKey">0000921114</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="armp-20241202.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-12-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000921114</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-02</xbrli:startDate>
        <xbrli:endDate>2024-12-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90C_edei--DocumentType_c20241202__20241202_zCuB6hlGTIZa"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 OR  15(d) of
the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_90D_edei--DocumentPeriodEndDate_c20241202__20241202_zzy13prz4Om5"><ix:nonNumeric contextRef="AsOf2024-12-02" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 2, 2024</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b><span id="xdx_903_edei--EntityRegistrantName_c20241202__20241202_zWEE86wuxS23"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000011" name="dei:EntityRegistrantName">ARMATA PHARMACEUTICALS, INC.</ix:nonNumeric></span></b></span></p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20241202__20241202_zpyK9vpqZzXb"><ix:nonNumeric contextRef="AsOf2024-12-02" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Washington</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityFileNumber_c20241202__20241202_zqwW9Qt5JbK3"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000013" name="dei:EntityFileNumber">001-37544</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20241202__20241202_zUOn2M0YGao9"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000014" name="dei:EntityTaxIdentificationNumber">91-1549568</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or other jurisdiction of<br/>
 incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(IRS Employer Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: Black 1pt solid; text-align: center; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_90A_edei--EntityAddressAddressLine1_c20241202__20241202_zJxdq04sWRd7"><b><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000015" name="dei:EntityAddressAddressLine1">5005
McConnell Avenue</ix:nonNumeric></b></span><b>,</b><b> <span id="xdx_90F_edei--EntityAddressCityOrTown_c20241202__20241202_zt3aYpPFlpYe"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000016" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span></b><b>,
<span id="xdx_90C_edei--EntityAddressStateOrProvince_c20241202__20241202_z389FCBolh3"><ix:nonNumeric contextRef="AsOf2024-12-02" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; width: 49%; padding-right: 5.4pt; padding-left: 5.4pt"><b></b> <b><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20241202__20241202_zyQWKrS6rM45"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000018" name="dei:EntityAddressPostalZipCode">90066</ix:nonNumeric></span></b></td></tr>
<tr style="vertical-align: top">
<td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td>&#160;</td>
<td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_908_edei--CityAreaCode_c20241202__20241202_z7wc9nhWHp55"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000019" name="dei:CityAreaCode">310</ix:nonNumeric></span>) <span id="xdx_907_edei--LocalPhoneNumber_c20241202__20241202_z5uEamxxRJr5"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000020" name="dei:LocalPhoneNumber">655-2928</ix:nonNumeric></span></b></p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_903_edei--WrittenCommunications_c20241202__20241202_zjbMjpKpN26b"><ix:nonNumeric contextRef="AsOf2024-12-02" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_90B_edei--SolicitingMaterial_c20241202__20241202_zygl0pUqDHV4"><ix:nonNumeric contextRef="AsOf2024-12-02" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementTenderOffer_c20241202__20241202_zTnJcDw5UkX1"><ix:nonNumeric contextRef="AsOf2024-12-02" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20241202__20241202_zDBR8t7kak61"><ix:nonNumeric contextRef="AsOf2024-12-02" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Emerging Growth Company&#160;<span style="font-family: Wingdings"><span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20241202__20241202_zS9mEkQayAc5"><ix:nonNumeric contextRef="AsOf2024-12-02" format="ixt:booleanfalse" id="Fact000025" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 31%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><span style="font-size: 10pt">Title
    of each class</span></td>
    <td style="vertical-align: bottom; width: 1%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 30%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><span style="font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="vertical-align: bottom; width: 1%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 37%; padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><span style="font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><b><span style="font-size: 10pt"><span id="xdx_906_edei--Security12bTitle_c20241202__20241202_zvdL8OPFt86b"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000026" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></b></td>
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><b><span style="font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20241202__20241202_zURF6oVzPM5b"><ix:nonNumeric contextRef="AsOf2024-12-02" id="Fact000027" name="dei:TradingSymbol">ARMP</ix:nonNumeric></span></span></b></td>
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-right: 1.5pt; padding-left: 1.5pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_903_edei--SecurityExchangeName_c20241202__20241202_zfyrGWgMmxxf"><ix:nonNumeric contextRef="AsOf2024-12-02" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">NYSE American</ix:nonNumeric></span></b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 72px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5.02</b></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(e)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;15,
2024, Armata Pharmaceuticals,&#160;Inc. (the &#8220;<i>Company</i>&#8221;) disclosed that it had reached an agreement with Mina Pastagia,
M.D. (&#8220;<i>Dr.&#160;Pastagia</i>&#8221;), the Company&#8217;s Chief Medical Officer, pursuant to which Dr.&#160;Pastagia&#8217;s
employment had concluded effective as of November&#160;13, 2024 (the &#8220;<i>Termination Date</i>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection
with Dr.&#160;Pastagia&#8217;s separation, on December&#160;2, 2024, the Company entered into a Separation and Release Agreement with
Dr.&#160;Pastagia (the &#8220;<i>Separation Agreement</i>&#8221;) pursuant to which, in consideration for Dr.&#160;Pastagia&#8217;s general
release of claims in favor of the Company and its affiliates, Dr.&#160;Pastagia will be entitled to the continued payment of her base
salary for twelve (12) months following the Termination Date. Dr.&#160;Pastagia&#8217;s receipt of the foregoing payments is subject to
her non-revocation of and compliance with the Separation Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing
summary of the Separation Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text
of the Separation Agreement, a copy of which is attached as Exhibit&#160;10.1 to this report and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
  <td style="width: 72px"><b>Item 9.01. </b></td>
  <td><b>Financial Statements and Exhibits.</b></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: white">
    <td><a href="tm2430081d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td style="width: 89%"><a href="tm2430081d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separation and Release Agreement, by and between Armata Pharmaceuticals,&#160;Inc. and Mina Pastagia, M.D., dated as of December&#160;2, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Cover Page&#160;Interactive Data File (embedded within XBRL document)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: December 4, 2024</span></td>
    <td colspan="2" style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armata Pharmaceuticals,&#160;Inc.</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </span></td>
    <td style="border-bottom: black 1pt solid; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David House</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David House</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Vice President, Finance and Principal Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</span></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2OkzXovAysYgsQiK6XXKMJd2R2e3vkXrLNiUaBobhnO8cIUZiRUvdIMNpURZwwLZrlEMosUZGc0bvyNabFPwt8aKtY2Vc//7AjDyDnpmGMlFe6K13bbFKIZqPZTKWE4hkOpnBfiuCr56RqXWFxmnVgDIV7Jk61ugUv4aEg3qSofbVVx2RrSaTQhxGg/wGGcUSdnRXD+KrhaLIRDDqJxArplvnXfnTofmSkDfY+jo70P8NPgqFSpM= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2430081d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SEPARATION AND RELEASE AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Separation and Release
Agreement (this&nbsp;&ldquo;<B><I>Agreement</I></B>&rdquo;), originally delivered November&nbsp;13, 2024, confirms the following understandings
and agreements between Armata Pharmaceuticals,&nbsp;Inc. (the&nbsp;&ldquo;<B><I>Company</I></B>&rdquo;) and Mina Pastagia, M.D. (hereinafter
referred to as &ldquo;<B><I>you</I></B>&rdquo; or &ldquo;<B><I>your</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the promises
set forth herein, you and the Company agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Opportunity
for Review; Acceptance</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;You
have until December&#8239;5, 2024 (the&#8239;&ldquo;<B><I>Review Period</I></B>&rdquo;), to review and consider this Agreement. To accept
this Agreement, and the terms and conditions contained herein, prior to the expiration of the Review Period, you must execute and date
this Agreement where indicated below and return the executed copy of this Agreement to Deborah Birx (the&#8239;&ldquo;<B><I>Company Representative</I></B>&rdquo;),
Chief Executive </FONT>Officer, 5005 McConnell Avenue, Los Angeles, California 90066, by email (dbirx@armatapharma.com), or by a recognized
national overnight courier service to the address specified above or by other electronic copies (complying with the U.S. federal ESIGN
Act of 2000 (<I>e</I>.<I>g</I>., DocuSign)). You acknowledge that, to the extent there are changes made to the terms of this Agreement
after the date hereof, whether they are material or immaterial, the Review Period is not recommenced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
anything contained herein to the contrary, this Agreement will not become effective or enforceable for a period of seven (7)&#8239;calendar
days following the date of your execution of this Agreement (the&#8239;&ldquo;<B><I>Revocation Period</I></B>&rdquo;), during which time
you may revoke your acceptance of this Agreement by notifying the Company Representative, in writing, as specified above. To be effective,
such revocation must be received by the Company Representative no later than 11:59 p.m.&#8239;Pacific Time on the seventh (7<SUP>th</SUP>)
calendar day following your execution of this Agreement. Provided that this Agreement is executed during the Review Period and you do
not revoke it during the Revocation Period, the eighth (8<SUP>th</SUP>) calendar day following the date on which this Agreement is executed
and delivered to the Company Representative shall be its effective date (the&#8239;&ldquo;<B><I>Effective Date</I></B>&rdquo;). In the
event that you fail to execute and deliver this Agreement prior to the expiration of the Review Period or, if you revoke this Agreement
during the Revocation Period, this Agreement will be null and void and of no effect, and neither you nor the Company nor any other member
of the Company Group (as defined below) will have any obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Employment
Status; Accrued Benefits; Separation Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Employment
Status</I>. You acknowledge and agree that your employment with the Company and, to the extent applicable, any of its direct and indirect
parent(s), subsidiaries, and affiliates (collectively, with the Company, the&#8239;&ldquo;<B><I>Company Group</I></B>&rdquo;), terminated
effective as of the close of business on November&#8239;13, 2024 (the&#8239;&ldquo;<B><I>Separation Date</I></B>&rdquo;), and after the
Separation Date, you will not represent yourself as being an employee, officer, agent, or representative of the Company or any other member
of the Company Group. You hereby confirm your resignations from all offices, directorships, trusteeships, committee memberships and fiduciary
and other capacities held with, or on behalf of, the Company Group effective as of the Separation Date and your execution of this Agreement
will be deemed the grant by you to the officers of the Company of a limited power of attorney to sign in your name and on your behalf
any such documentation as may be required to be executed solely for the limited purposes of effectuating such resignations. You agree
that within five (5)&#8239;business days following the Separation Date, you will update your accounts or profiles on any social media platform
(including, but not limited to, Facebook, X (formerly known as Twitter) or LinkedIn) to reflect that you are no longer actively employed
by or affiliated with the Company Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Accrued
Benefits</I>. The Separation Date shall be the termination date of your employment for purposes of participation in and coverage under
all employee benefit plans and programs or arrangements sponsored by or through the Company and any other member of the Company Group
in which you are eligible to participate, except as otherwise provided herein. </FONT>Regardless of whether you sign this Agreement, you
will be paid for (i)&#8239;all of your earned but unpaid salary through the Separation Date on the Separation Date, (ii)&#8239;any accrued
but unused vacation through the Separation Date, and (iii)&#8239;any business expenses incurred by you prior to the Separation Date and
properly submitted in accordance with the Company&rsquo;s policies and procedures within ten (10)&#8239;days following the Separation Date.
In addition, if applicable, you will be entitled to continued medical and health benefits under the Consolidated Omnibus Budget Reconciliation
Act of 1985 (&ldquo;<B><I>COBRA</I></B>&rdquo;), and additional information concerning such benefits will be provided to you under separate
cover following the Separation Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Separation
Benefits</I>. In consideration of your promises herein, and subject to your execution, delivery and non-revocation of this Agreement and
your continued compliance with this Agreement, the Company will provide you with an amount equal to twelve (12) months of your base salary
(at the rate in effect immediately prior to the Separation Date), such amount to be paid in substantially equal installments over a period
of twelve (12) months commencing on the first regularly scheduled payroll date following the sixtieth (60<SUP>th</SUP>) day following
the Separation Date (the &ldquo;<B><I>Consideration</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Deferral
of Payments</I>. Notwithstanding the foregoing, in the event that any amount would otherwise have been payable as a result of paragraph
2(c)&#8239;above prior to the Effective Date, such amount shall not be paid until the first regularly scheduled payroll date that is at
least five (5)&#8239;business days following the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Full
Discharge. </I>You acknowledge and agree that the payment(s)&#8239;and other benefits provided pursuant to this paragraph&#8239;2 are in
full satisfaction and discharge of any and all liabilities and obligations of the Company or any other member of the Company Group to
you, monetarily, with respect to employee benefits or otherwise, including, but not limited to, any and all obligations, including, without
limitation, notice and severance obligations, arising under that certain employment letter agreement between you and the Company, dated
September&#8239;22, 2020, as amended by that certain Amendment No.&#8239;1 to Employment Agreement between you and the Company, dated July&#8239;22,
2024 (collectively, the&#8239;&ldquo;<B><I>Employment Agreement</I></B>&rdquo;), any other alleged written or oral employment agreement,
policy, plan or procedure of the Company or any other member of the Company Group and/or any alleged understanding or arrangement between
you and the Company or any other member of the Company Group (other than claims for accrued and vested benefits under an employee benefit,
insurance, or pension or other retirement plan of the Company or any other member of the Company Group (excluding any severance or similar
plan or policy), subject to the terms and conditions of such plan(s)). You further acknowledge and agree that, as of the Separation Date,
all outstanding, unvested options and restricted stock units held by you will be forfeited and that any vested options are subject to
forfeiture to the extent not exercised during the ninety (90) days immediately following the Separation Date</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Taxes.
</I></FONT>The Company Group will withhold all applicable taxes, including, but not limited to, income, employment and social insurance
taxes, as shall be required by law, from the amounts and benefits provided hereunder, including, without limitation, the Consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Release
and Waiver of Claims</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;As
used in this Agreement, the term &ldquo;</FONT><B><I>claims</I></B>&rdquo; will mean all claims, covenants, warranties, promises, undertakings,
actions, suits, causes of action, obligations, debts, accounts, attorneys&rsquo; fees, judgments, losses and liabilities, of whatsoever
kind or nature, in law, equity or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
and in consideration of the payments and benefits described in paragraph&#8239;2 above, and other good and valuable consideration, you,
for and on behalf of yourself and your heirs, administrators, executors and assigns, effective as of the Effective Date, do fully and
forever release, remise and discharge each member of the Company Group (including any co-employer of any member of the Company Group)
and each of their successors and assigns, together with their respective current and former officers, directors, partners, members, stockholders
(including any management company of a member or stockholder), employees and agents (collectively, and with the Company, the&#8239;&ldquo;<B><I>Company
Parties</I></B>&rdquo;) from any and all claims whatsoever up to the date you execute this Agreement which you had, may have had, or now
have against the Company Parties, whether known or unknown, for or by reason of any matter, cause or thing whatsoever, including any claim
arising out of or attributable to your employment or the termination of your employment with the Company or any member of the Company
Group, whether for tort, breach of express or implied contract, intentional infliction of emotional distress, wrongful termination, unjust
dismissal, violation of public policy, defamation, libel or slander, or under any federal, state or local law dealing with discrimination,
harassment or retaliation, and any other purported restriction on an employer&rsquo;s right to terminate the employment of employees.
This release of claims includes, but is not limited to, all claims arising under Title VII of the Civil Rights Act of 1964, the Age Discrimination
in Employment Act of 1967, as amended (the&#8239;&ldquo;<B><I>ADEA</I></B>&rdquo;), the Americans with Disabilities Act of 1990, the Civil
Rights Act of 1991, the Family and Medical Leave Act of 1993, the Equal Pay Act of 1963, the Worker Adjustment and Retraining Notification
Act of 1988 and the Employee Retirement Income Security Act of 1974 (excluding claims for accrued, vested benefits under any retirement,
pension or other employee benefit plan of the Company Parties (other than any severance or similar plan or policy)), each as may be amended
from time to time, and all other federal, state and local laws, the common law or constitution of any jurisdiction. You intend the release
contained herein to be a general release of any and all claims to the fullest extent permissible by law and for the provisions regarding
the release of claims against the Company Parties to be construed as broadly as possible, and hereby incorporate in this release similar
federal, state or other laws, all of which you also hereby expressly waive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>You
understand and agree that claims or facts in addition to or different from those which are now known or believed by you to exist may hereafter
be discovered, but it is your intention to fully and forever release, remise and discharge all claims which you had, may have had, or
now have against the Company Parties, whether known or unknown, suspected or unsuspected, asserted or unasserted, contingent or noncontingent,
without regard to the subsequent discovery or existence of such additional or different facts. Without limiting the foregoing, by signing
this Agreement, you expressly waive and release any provision of law that purports to limit the scope of a general release, including
any and all rights and benefits under Section&#8239;1542 of the Civil Code of the State of California (or any analogous law of any other
state, to the extent applicable), which provides as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;A GENERAL RELEASE DOES NOT EXTEND
TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE
AND THAT,&#8239;IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;You
acknowledge and agree that as of the date you execute this Agreement, you have no knowledge of any facts or circumstances that give rise
or could give rise to any claims under any of the laws listed in the preceding paragraphs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
any provision of this Agreement to the contrary, by executing this Agreement, you are not releasing any claims relating to: (i)&#8239;your
rights with respect to payment and benefits under this Agreement; (ii)&#8239;your right to accrued, vested benefits due to terminated employees
under any employee benefit plan of the Company or any other member of the Company Group in which you participated (excluding any severance
or similar plan or policy), in accordance with the terms thereof (including your right to elect COBRA continuation coverage); (iii)&#8239;any
claims that cannot be waived by law or that arise after the date you execute this Agreement; (iv)&#8239;your right to indemnification,
advancement and reimbursement of legal fees and expenses, and directors and officers liability insurance, as provided by, and in accordance
with the terms of, applicable law, the Company&rsquo;s by-laws or otherwise; (v)&#8239;your rights as a stockholder or optionholder of
the Company; or (vi)&#8239;your right to unemployment insurance benefits (application for which shall not be contested by the Company,
provided that the Company shall truthfully respond to any government inquiries concerning you).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
any provision of this Agreement to the contrary, nothing herein or in any Company policy or agreement prevents you, without notifying
the Company, from (i)&#8239;speaking with law enforcement, your attorney, the attorney general, the U.S. Equal Employment Opportunity Commission
or any state or local division of human rights or fair employment agency; (ii)&#8239;filing a charge or complaint with, participating in
an investigation or proceeding conducted by, or reporting possible violations of law or regulation to any government agency; (iii)&#8239;participating
in a whistleblower program administered by the U.S. Securities and Exchange Commission or any other government agency; (iv)&#8239;truthfully
testifying in a legal proceeding or responding to or complying with a subpoena, court order, or other legal process; (v)&#8239;filing or
disclosing any facts necessary to receive unemployment insurance, Medicaid, or other public benefits to which you may be entitled; or
(vi)&#8239;discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other
conduct that you have reason to believe is unlawful; </B></FONT><B><I>provided</I>, <I>however</I>, in each case, you agree to forgo any
monetary benefit from the filing of a charge or complaint with a government agency except pursuant to a whistleblower program or where
your right to receive such a monetary benefit is otherwise not waivable by law.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;You
acknowledge and agree that as of the date you execute this Agreement, you have reported all accidents, injuries or illnesses relating
to or arising from your employment with the Company or the Company Group and that you have not suffered any on-the-job injury or illness
for which you have not yet filed a claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;By
signing below, you represent and warrant to the Company that (i)&#8239;prior to the date you execute this Agreement, you have provided
the Company with written disclosure of any unethical or illegal behavior and any material violations of the Company&rsquo;s code of ethics
or other material policy, in each case, that you observed, suspected or became aware of during the course of your employment or, if no
such written disclosure was provided, that you have not observed, suspected or become aware of any such behavior or violations and (ii)&#8239;you
have complied with all laws and Company policies in respect of your employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Knowing
and Voluntary Waiver</U>. You expressly acknowledge and agree that you:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;are
able to read the language, and understand the meaning and effect, of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;have
no physical or mental impairment of any kind that has interfered with your ability to read and understand the meaning of this Agreement
or its terms, and that you are not acting under the influence of any medication, drug or chemical of any type in entering into this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;are
specifically agreeing to the terms of the release contained in this Agreement because the Company has agreed to provide you the Consideration,
which the Company has agreed to provide because of your agreement to accept it in full settlement of all possible claims you might have
or ever had against the Company Parties, and because of your execution of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;acknowledge
that, but for your execution of this Agreement, you would not be entitled to the Consideration;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;had
or could have the entire Review Period in which to review and consider this Agreement, and that if you execute this Agreement prior to
the expiration of the Review Period, you have voluntarily and knowingly waived the remainder of the Review Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;understand
that, by entering into this Agreement, you do not waive rights or claims under the ADEA that may arise after the date you execute this
Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;have
not relied upon any representation or statement not set forth in this Agreement made by the Company Group or any of its representatives;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;are
hereby advised to consult with your attorney regarding the terms and effect of this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;have
signed this Agreement knowingly and voluntarily.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Suit</U>. You represent and warrant that you have not previously filed and, except as otherwise provided in paragraph&#8239;3(f)&#8239;and
to the maximum extent permitted by law, you agree that you will not file, a complaint, charge or lawsuit against any of the Company Parties
regarding any of the claims released herein. Except as otherwise provided in paragraph&#8239;3(f), </FONT>if, notwithstanding this representation
and warranty, you have filed or file such a complaint, charge or lawsuit, you agree that you shall cause such complaint, charge or lawsuit
to be dismissed with prejudice and shall pay any and all costs required in obtaining dismissal of such complaint, charge or lawsuit, including,
without limitation, the attorneys&rsquo; fees of any of the Company Parties against whom you have filed such a complaint, charge or lawsuit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Re-Employment</U>. You hereby agree to waive any and all claims to re-employment with the Company or any of </FONT>its direct or indirect
parent(s)&#8239;or subsidiaries. You affirmatively agree not to seek further employment with the Company or any its direct or indirect
parent(s)&#8239;or subsidiaries. You acknowledge that if you re-apply for or seek employment with the Company or any of its direct or indirect
parent(s)&#8239;or subsidiaries, the refusal to hire you based on this provision will provide a complete defense to any claims arising
from your attempt to apply for employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. The provisions hereof shall inure to the benefit of your heirs, executors, administrators, legal personal representatives
and assigns and shall be binding upon your heirs, executors, administrators, legal personal representatives and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability;
Third-Party Beneficiaries</U>. If any provision of this Agreement shall be held by any court of competent jurisdiction to be illegal,
void or unenforceable, such provision shall be of no force and effect. The illegality or unenforceability of such provision, however,
shall have no effect upon and shall not impair the enforceability of any other provision of this Agreement. You acknowledge and agree
that each of the Company Parties shall be a third-party beneficiary to the releases set forth in paragraph&#8239;3 above, with full rights
to enforce this Agreement and the matters documented herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Cooperation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;You
agree that you will provide reasonable cooperation to the Company and/or any other member of the Company Group and its or their respective
counsel in connection with any investigation, administrative proceeding or litigation relating to any matter that occurred during your
employment in which you were involved or of which you have knowledge. The Company agrees to reimburse you for reasonable out-of-pocket
expenses incurred by you at the request of the Company with respect to your compliance with this paragraph&#8239;9(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Except
as otherwise provided in paragraph&#8239;3(f)&#8239;above, you agree that, in the event you are subpoenaed by any person or entity (including,
but not limited to, any government agency) to give testimony or provide documents (in a deposition, court proceeding or otherwise) which
in any way relates to your employment by the Company and/or any other member of the Company Group, you will give prompt written notice
of such request to the Company Representative, in writing, as specified above (or the Company Representative&rsquo;s successor or designee)
and will make no disclosure until the Company and/or the other member of the Company Group has had a reasonable opportunity to contest
the right of the requesting person or entity to such disclosure. The Company agrees to reimburse you for reasonable out-of-pocket expenses
incurred by you at the request of the Company with respect to your compliance with this paragraph&#8239;9(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Affirmation
of Continuing Obligations; Confidential Information; Non-Disparagement Covenant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;You
hereby acknowledge and agree that you have and will continue to comply with all of your ongoing obligations to any member of the Company
Group under any confidentiality, invention assignment, non-disparagement or similar agreement or arrangement to which you are a party
with any member of the Company Group, including, without limitation, the obligations set forth in this paragraph 10 (the&#8239;&ldquo;<B><I>Restrictive
Covenants</I></B>&rdquo;), which obligations are hereby incorporated into this Agreement and shall survive the termination of your employment
with the Company subject to the exceptions otherwise provided in paragraph&#8239;<B><I>&lrm;</I></B>3(f)&#8239;above, and you hereby acknowledge,
reaffirm and ratify your continuing obligations to the Company Group pursuant to such agreements or arrangements subject to paragraph&#8239;<B><I>&lrm;</I></B>3(f)&#8239;above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company&rsquo;s Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;By
signing below, you understand and acknowledge your employment by the Company created a relationship of confidence and trust with respect
to the Company Group&rsquo;s Confidential Information (as defined below) and that the Company Group has a protectable interest therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;At
all times during and after your employment, you agree to hold in confidence and not to disclose, use, lecture upon, or publish any of
the Company Group&rsquo;s Confidential Information unless the Chief Executive Officer of the Company expressly authorizes such disclosure.
You will obtain the Company&rsquo;s written approval before publishing or submitting for publication any material (written, oral, or otherwise)
that discloses and/or incorporates any Confidential Information. You hereby assign to the Company any rights you may have or acquire in
such Confidential Information and recognize that all Confidential Information is and shall be the sole and exclusive property of the Company
Group and its assigns. You will take all reasonable precautions to prevent the inadvertent accidental disclosure of Confidential Information.
The foregoing, or anything to the contrary in this Agreement or any other agreement between the Company Group and me, notwithstanding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Pursuant
to 18 U.S.C. Section&#8239;1833(b), you shall not be held criminally or civilly liable under any Federal or State trade secret law for
the disclosure of a trade secret that: (I)&#8239;is made in confidence to a Federal, State, or local government official, either directly
or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (II)&#8239;is
made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;It
is understood that, at all such times, you are free to use information which was known to you prior to employment with the Company or
which is generally known in the trade or industry through no breach of this paragraph 10(b)&#8239;or other act or omission by you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">C)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;You
understand that this paragraph 10(b)&#8239;is subject to the limitations set forth in paragraph&#8239;<B><I>&lrm;</I></B>3(f)&#8239;above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
term &ldquo;</FONT><B><I>Confidential Information</I></B>&rdquo; shall mean any and all confidential knowledge, data or information of
the Company Group. By way of illustration but not limitation, &ldquo;Confidential Information&rdquo; includes (a)&#8239;trade secrets,
inventions, ideas, processes, formulas, data, programs, other works of authorship, know-how, improvements, discoveries, developments,
designs, techniques, assay components, biological materials, cell lines, clinical data and any other proprietary technology and all trade
secrets, Copyrights, trademarks, mask work rights, patents and other intellectual property rights recognized by the laws of any jurisdiction
or country therein; (b)&#8239;information regarding research, development, new products, marketing and selling, business plans, budgets
and unpublished financial statements, licenses, prices and costs, margins, discounts, credit terms, pricing and billing policies, quoting
procedures, methods of obtaining business, forecasts, future plans and potential strategies, financial projections and business strategies,
operational plans, financing and capital-raising plans, activities and agreements, internal services and operational manuals, methods
of conducting Company business, suppliers and supplier information, and purchasing; (c)&#8239;information regarding customers and potential
customers of the Company Group, including customer lists, names, representatives, their needs or desires with respect to the types of
products or services offered by Company Group, proposals, bids, contracts and their contents and parties, the type and quantity of products
and services provided or sought to be provided to customers and potential customers of Company Group and other non-public information
relating to customers and potential customers; (d)&#8239;information regarding any of the Company Group&rsquo;s business partners and their
services, including names; representatives, proposals, bids, contracts and their contents and parties, the type and quantity of products
and services received by Company Group, and other non-public information relating to business partners; (e)&#8239;information regarding
personnel, employee lists, compensation, and employee skills; (f)&#8239;any other non-public information which a competitor of the Company
Group could use to the competitive disadvantage of the Company Group; and (g)&#8239;the existence of any business discussions, negotiations,
or agreements between the Company Group and any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>You
understand, in addition, that the Company Group has received from third parties their confidential and/or proprietary knowledge, data
or information (&ldquo;<B><I>Third Party Information</I></B>&rdquo;) subject to a duty on the Company Group&rsquo;s part to maintain the
confidentiality of such information and to use it only for certain limited purposes. You will hold Third Party Information in confidence
and will not disclose to anyone or use unless expressly authorized by the Chief Executive Officer of Company in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>You
understand that there is no temporal limitation on your obligation not to use or disclose Confidential Information and Third-Party Information,
as provided in this paragraph 10(b). If a temporal limitation on your obligation not to use or disclose such information is required under
applicable law, and the Agreement or its restriction(s)&#8239;cannot otherwise be enforced, you agree and the Company agree that the two
(2)-year period after the Separation Date will be the temporal limitation applicable to the contested restriction, <I>provided</I>, <I>however</I>,
that this sentence will not apply to trade secrets protected without temporal limitation under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(6)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;During
your employment by the Company, you represent that you did not improperly use or disclose confidential information or trade secrets, if
any, of any former employer or any other person to whom you have or had an obligation of confidentiality, and that you did not bring onto
the premises of the Company Group any unpublished documents or any property belonging to any former employer or any other person to whom
you have or had an obligation of confidentiality unless consented to in writing by that former employer or person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
as otherwise provided in paragraph&#8239;<B><I>&lrm;</I></B>3(f)&#8239;above, you agree that you will make no disparaging or defamatory
comments regarding any of the Company Parties in any respect. Your obligations under this paragraph&#8239;<B><I>&lrm;</I></B>10(c)&#8239;extend
to, but are not limited to, text messages, e-mail communications, and comments or postings on blogs, comment boards or social media websites
including, but not limited to, Facebook, X (formerly known as Twitter) or LinkedIn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;You
hereby acknowledge that your continued compliance with the obligations set forth in this paragraph <B><I>&lrm;</I></B>10 is a condition
of your receiving the Consideration described in paragraph&#8239;2</FONT> above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Return
of Property</U>. You agree that you will promptly return to the Company (or, if in electronic form and not unique, permanently delete),
and you will retain no copies in any form (including electronic) of, </FONT>all property belonging to the Company and/or any other member
of the Company Group, including but not limited to all proprietary and/or confidential information and documents (including any copies
thereof) in any form (including email) belonging to the Company, cell phone, iPhone or other mobile device, keys, credit card, identification
card or badge, access card, employee handbook, laptop, computer or other office equipment, computer user name and password, disks, data
files, thumb drives, and/or voicemail code. If you discover after the Separation Date that you have retained any proprietary and/or confidential
information (including, without limitation, proprietary and/or confidential information contained in any electronic documents or email
systems in your possession or control), you agree immediately upon discovery to send an email to the Company Representative to inform
the Company of the nature and location of the proprietary and/or confidential information that you have retained so that the Company may
arrange to remove, recover, and/or collect such information. You further acknowledge and agree that the Company shall have no obligation
to provide the Consideration described in paragraph&#8239;2 above unless and until you have satisfied all your obligations pursuant to
this paragraph&#8239;11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Non-Admission</U>.
Nothing contained in this Agreement will be deemed or construed as an admission of wrongdoing or liability on the part of you or any member
of the Company Group. Accordingly, this Agreement is inadmissible except in an action to enforce it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Entire
Agreement</U>. This Agreement and the Restrictive Covenants constitute the entire understanding and agreement of the parties hereto regarding
the termination of your employment. This Agreement and the Restrictive Covenants supersede all prior negotiations, discussions, correspondence,
communications, understandings and agreements between the parties relating to the subject matter of this Agreement and the Restrictive
Covenants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Attorneys&rsquo;
Fees and Costs</U>. You hereby acknowledge and agree that, except as provided in paragraph&#8239;16 (<I>Arbitration</I>), the Company Parties
are entitled to recover from you all reasonable attorneys&rsquo; fees and costs associated with their efforts to enforce this Agreement
or the Restrictive Covenants and/or to recover damages for a breach of this Agreement or the Restrictive Covenants by you, and/or which
are incurred by the Company Parties as a result of a breach of this Agreement or the Restrictive Covenants by you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law; Jurisdiction</U>. EXCEPT WHERE PREEMPTED BY FEDERAL LAW, THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF CALIFORNIA, APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN THAT STATE, WITHOUT REGARD TO CONFLICT OF LAWS RULES.
BY EXECUTION OF THIS AGREEMENT, EACH PARTY TO THIS AGREEMENT HEREBY CONSENTS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS
LOCATED IN THE STATE OF CALIFORNIA AND HEREBY WAIVES ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY DISPUTE ARISING UNDER OR CONCERNING
THIS AGREEMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Arbitration</U>.
</FONT>EXCEPT WHERE PREEMPTED BY FEDERAL LAW, ALL DISPUTES ARISING UNDER OR CONCERNING THIS AGREEMENT, EXCEPT CLAIMS FOR IMMEDIATE INJUNCTIVE
RELIEF AS REFERENCED BELOW, AS WELL AS ALL CLAIMS ARISING OUT OF YOUR EMPLOYMENT OR THE TERMINATION THEREOF,&#8239;INCLUDING WITHOUT LIMITATION
ALL CLAIMS FOR PAYMENT OF WAGES, DISCRIMINATION, RETALIATION, AND ALL OTHER CLAIMS BASED ON ANY STATE, FEDERAL OR COMMON LAW WILL BE RESOLVED
THROUGH BINDING ARBITRATION BEFORE A SINGLE ARBITRATOR PURSUANT TO THE FEDERAL ARBITRATION ACT.&#8239; THE ARBITRATION SHALL BE ADMINISTERED
BY JAMS, UNDER ITS THEN APPLICABLE RULES FOR EMPLOYMENT DISPUTES.&#8239; IF JAMS CANNOT SERVE AS THE ARBITRATION ADMINISTRATOR, THEN THE
ARBITRATION WILL BE THROUGH THE AMERICAN ARBITRATION ASSOCIATION, UNDER ITS THEN APPLICABLE RULES FOR EMPLOYMENT DISPUTES.&#8239; THE COMPANY
SHALL PAY ALL ARBITRATION FEES IN EXCESS OF THE ADMINISTRATIVE FEES THAT YOU WOULD BE REQUIRED TO PAY IF THE DISPUTE WERE DECIDED IN A
COURT OF LAW.&#8239; THE EXCLUSIVE VENUE OF ANY SUCH ARBITRATION WILL BE LOS ANGELES, CALIFORNIA.&#8239; THE NON-PREVAILING PARTY WILL PAY
THE REASONABLE ATTORNEYS&rsquo; FEES AND COSTS OF THE PREVAILING PARTY.&#8239; THE ARBITRATOR SHALL HAVE AUTHORITY TO ISSUE EQUITABLE AND
LEGAL RELIEF,&#8239;INCLUDING WITHOUT LIMITATION INJUNCTIVE RELIEF AND MONETARY DAMAGES, BUT THE ARBITRATOR MAY&#8239;NOT CONSOLIDATE THE
CLAIMS OF MORE THAN ONE PERSON OR ENTITY, NOR MAY&#8239;THE ARBITRATOR PRESIDE OVER ANY FORM&#8239;OF REPRESENTATIVE OR CLASS&#8239;PROCEEDING.&#8239;
QUESTIONS OF WHETHER A CLAIM IS SUBJECT TO ARBITRATION UNDER THIS AGREEMENT SHALL BE DECIDED BY THE ARBITRATOR.&#8239; ALL ARBITRATION
PROCEEDINGS SHALL BE CONFIDENTIAL.&#8239; THIS ARBITRATION PROVISION DOES NOT PREVENT EITHER PARTY FROM SEEKING IMMEDIATE INJUNCTIVE RELIEF
IN COURT TO REMEDY A BREACH OR THREATENED BREACH OF THIS AGREEMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Construction</U>.
The section or paragraph headings or titles herein are for convenience of reference only and shall not be deemed a part of this Agreement.
The parties hereto acknowledge and agree that each party has reviewed and negotiated the terms and provisions of this Agreement and has
had the opportunity to contribute to its revision. Accordingly, the rule&#8239;of construction to the effect that ambiguities are resolved
against the drafting party, including, but not limited to Section&#8239;1654 of the California Civil Code, shall not be employed in the
interpretation of this Agreement. Rather, the terms of this Agreement shall be construed in a reasonable manner to effect the intentions
of both parties hereto and not in favor or against either party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Section&#8239;409A</U>.
Payments made under this Agreement are intended to be exempt from, or comply with, Section&#8239;409A of the Internal Revenue Code of 1986,
as amended (&ldquo;<B><I>Section&#8239;409A</I></B>&rdquo;), and this Agreement will be interpreted to achieve this result. For purposes
of this Agreement, each payment in a series of payments hereunder shall be deemed to be a separate payment for purposes of Section&#8239;409A.
In no event is the Company responsible for any tax or penalty owed by you (other than for withholding obligations or other obligations
applicable to employers, if any, under Section&#8239;409A) with respect to payments under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Counterparts</U>.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which shall constitute one and the
same instrument</FONT>, and electronically delivered copies of executed counterparts shall be deemed to be originals for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#9;&#8239;&#8239;&#8239;&#8239;&#8239;*&#9;&#8239;&#8239;&#8239;&#8239;&#8239;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have executed this Agreement as of the date set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 50%">&#8239;</TD>
  <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="text-transform: uppercase"><B>armata pharmaceuticals, inc.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&#8239;</TD>
  <TD STYLE="text-align: justify; width: 3%">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Deborah Birx</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
  <TD STYLE="text-align: justify">&#8239;</TD>
  <TD STYLE="text-align: justify"><B>Deborah Birx, M.D.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
  <TD STYLE="text-align: justify">&#8239;</TD>
  <TD STYLE="text-align: justify">Chief Executive Officer</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
  <TD STYLE="text-align: justify">&#8239;</TD>
  <TD STYLE="text-align: justify">&#8239;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
  <TD COLSPAN="2" STYLE="text-align: justify"><B>EMPLOYEE</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
  <TD STYLE="text-align: justify">&#8239;</TD>
  <TD STYLE="text-align: justify">&#8239;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mina Pastagia</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
  <TD COLSPAN="2"><B>Mina Pastagia, M.</B>D.</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
  <TD>&#8239;</TD>
  <TD>&#8239;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
  <TD COLSPAN="2">Dated: December&#8239;2, 2024</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&#8239;to M Pastagia Separation
and Release Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>armp-20241202.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaiDGbOdzZR+aYkxtmB5bZlafyErQFLovSLK58amYX0H -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:armp="http://armatapharma.com/20241202" elementFormDefault="qualified" targetNamespace="http://armatapharma.com/20241202">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://armatapharma.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="armp-20241202_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="armp-20241202_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>armp-20241202_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>armp-20241202_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://armatapharma.com/role/Cover" xlink:href="armp-20241202.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://armatapharma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45899615317472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 02, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  02,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARMATA PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000921114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1549568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5005
McConnell Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">655-2928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ARMP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " "C@(19EXJ[',
M   3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!
M5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]I
MSI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z
M3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=
MQ_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( *.
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MZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " "C@(19)!Z;HJT
M  #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O
M$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S
M)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^
M0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@
MXLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ HX"$6660
M>9(9 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;
M)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=
M]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T
M<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JK
MA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#
M(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[
M04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%0
M2P$"% ,4    " "C@(19!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *. A%E.[-9![P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M *. A%F97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ HX"$69FV;*5$!   <!   !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M *. A%F?H!OPL0(  .(,   -              "  8@,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ HX"$69>*NQS     $P(   L              ( !
M9 \  %]R96QS+RYR96QS4$L! A0#%     @ HX"$6:K$(A8S 0  (@(   \
M             ( !31   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *.
MA%DD'INBK0   /@!   :              "  :T1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *. A%EED'F2&0$  ,\#   3
M          "  9(2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  -P3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2430081d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://armatapharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>armp-20241202.xsd</File>
    <File>armp-20241202_lab.xml</File>
    <File>armp-20241202_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2430081d1_8k.htm">tm2430081d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2430081d1_8k.htm": {
   "nsprefix": "armp",
   "nsuri": "http://armatapharma.com/20241202",
   "dts": {
    "schema": {
     "local": [
      "armp-20241202.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "armp-20241202_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "armp-20241202_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2430081d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://armatapharma.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2430081d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2430081d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://armatapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-24-125505-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-125505-xbrl.zip
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MVA)7;$#F-!-F>1 L *9,!@H94CI4"+WTO+Y+P#+U$"/8'%/FE@"[R28%34U
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M:.N>)+\CXN*R'2I(PYGF=3.]@DI8"Q@WG5EEF\5ZAJAL\Y"P\5C'=CO?0#\
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MLC]4APYM>XL.C>&+<!JCM(+5U,0X+[.YG:]1$("Z 8F)(,T1-)G\;>>QS$8
M($D)_^(:K]*8#QMF!]QE(+'.D^B8Q 3.G:19#=#X&?]E23DC?6U[2W9@'GJ7
MI>5<[0#=17I,S(YTEEU>!6E\-,8(^'/ ZA1R0S)J[[-8^4.VS)--V3(^J"3I
M@G%A (A?YF3&9"7 ^T@G /D"OG%<&.;+!V/A;,@N06:P!%M2X)9T-NMWL0P!
M&+1]MU(6K>&>1$T5+YC/IZ#9@PCWF"K&Q+6B& 1/01.@ZH\?MK?@*.&5G1RD
M:5Z.P*") U!R<R;; %3O:0R\B_35Z92YV114BN8RB%O?I/T3 :\PJ4#?C).
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MTN($OII.69(1P1CO/9N1R\N6T M2E#!Q,"5SM'$O2]@#<L9P JP-V<T\6&1
M?RRGZY28QU_ #D0_[8N#AJ.VYI]%&V69%:/9KAI. P=[-IJW\</\3-&F5+$V
M9<H$4SKR\X!T**'+1@Q)$H#@K%.RT6*)^U;>:)+:C'W7:3F-'-V$7*XCS @"
MO*!H$:@N&$+-RVDA:AK8I<%\LKWUI.)%'!JM87W=2U['>586.5;%J,]Q_:_
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M/269IGC+,$U@RN7$U!2?0N344G#44YS6S>&=5CKKP7;#995R^YS3C&M)*;*
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MD/"R6); V4O\#_;U(HMX3K?:2#^0?"+1W'HA[AUQIDRF>,L!O3F)]5CY7-T
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M+\ "G1&Y$%_&NRVTO<Z5 DKI=-?5J^(9:08%)L!2 R4#*2ZNUQ1KX.%O[D_
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M]^\774"C#T"^??^TXY^H%M"0?P)K@0%A%?YI#R<?J(\^+ #^Q77(6&852)*
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M;7 M,C R-#$R,#(N>'-D4$L! A0#%     @ HX"$6=2E3)O^"@  @(8  !4
M             ( !6P,  &%R;7 M,C R-#$R,#)?;&%B+GAM;%!+ 0(4 Q0
M   ( *. A%E>5$FI60<  -U7   5              "  8P.  !A<FUP+3(P
M,C0Q,C R7W!R92YX;6Q02P$"% ,4    " "C@(19-EOTAI 3   @:   $@
M            @ $8%@  =&TR-#,P,#@Q9#%?.&LN:'1M4$L! A0#%     @
MHX"$69#K_P0F-P  <P<! !8              ( !V"D  '1M,C0S,# X,60Q
A7V5X,3 M,2YH=&U02P4&      4 !0!) 0  ,F$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm2430081d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="armp-20241202.xsd" xlink:type="simple"/>
    <context id="AsOf2024-12-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000921114</identifier>
        </entity>
        <period>
            <startDate>2024-12-02</startDate>
            <endDate>2024-12-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-12-02" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-12-02" id="Fact000004">0000921114</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-12-02" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-12-02" id="Fact000010">2024-12-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-12-02" id="Fact000011">ARMATA PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-12-02" id="Fact000012">WA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-12-02" id="Fact000013">001-37544</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-12-02" id="Fact000014">91-1549568</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-12-02" id="Fact000015">5005 McConnell Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-12-02" id="Fact000016">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-12-02" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-12-02" id="Fact000018">90066</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-12-02" id="Fact000019">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-12-02" id="Fact000020">655-2928</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-12-02" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-12-02" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-12-02" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-12-02" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-12-02" id="Fact000025">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="AsOf2024-12-02" id="Fact000026">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-12-02" id="Fact000027">ARMP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-12-02" id="Fact000028">NYSEAMER</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
